5 Things to Know Before the Stock Market Opens

Stock futures are higher and the S&P 500 and Nasdaq are on track for record highs, supported by upbeat risk sentiment. Cisco is surging in premarket trading after better-than-expected results and layoff plans tied to AI investment, while Cerebras's trading debut will test demand for new AI names. Doximity is plunging after missing profit and outlook estimates, and Trump-Xi trade discussions add a geopolitical backdrop to the session.

Analysis

The cleaner read-through is not “AI is hot,” but that capital is rotating toward businesses that can fund AI capex internally while showing near-term earnings leverage. Cisco’s move matters because it reinforces a two-tier market: incumbents with cash flow and installed bases can reposition as AI infrastructure beneficiaries, while pure-play growth names with weak guidance are being punished harder. That tends to compress dispersion within software/healthcare and create a better setup for relative-value rather than outright beta exposure.

Cerebras’ debut is a useful sentiment test because new AI listings are now competing against a higher hurdle rate: investors want a path to monetization, not just compute scarcity narratives. If the IPO trades well, it can temporarily re-open the window for adjacent private-to-public AI names and semis; if it weakens, expect a fast air-pocket in speculative AI baskets over the next 1-3 sessions as traders de-risk the theme. The second-order beneficiary of a strong debut is actually the broader networking/interop stack, where names tied to data-center buildouts can absorb incremental capital without needing perfect fundamentals.

Doximity’s miss is more important for healthcare internet/software sentiment than for the name itself. The market is signaling that “mission-critical” digital health still trades like a duration asset: any evidence of slower monetization gets marked down immediately, and that can spill over to other ad/lead-gen-driven healthcare platforms. With guidance risk now front-loaded into the next quarter, the group is vulnerable to multiple compression even if revenue stays stable.

Macro-wise, the Trump-Xi meeting lowers immediate trade tail-risk, but it does not eliminate supply-chain fragility; the market is still vulnerable to headline reversals around tariffs, tech export controls, and Taiwan language. That means the current risk-on tape is probably correct tactically, but fragile over a 1-4 week horizon if geopolitics re-enters as an input to semis or industrials. The base case is continued bid in quality tech, but the contrarian risk is that the market is underpricing how quickly one negative headline can unwind crowded AI longs.

Key Decisions for Investors

• Long CSCO into the next 1-2 weeks versus a basket of unprofitable AI infrastructure names: use it as a quality AI-enabler hedge with better downside support and better visibility on cash return; risk/reward favors 1-1.5x upside to downside if the market keeps rewarding self-funding AI stories.
• Fade weak healthcare software via short DOCS for 2-6 weeks or buy puts into any relief bounce: the miss likely resets valuation expectations across digital health, and the tape is now punishing guide-downs more than misses; target downside continuation if next-week analyst revisions accelerate.
• If Cerebras trades strongly on day 1, pair long a selective AI infra basket against short speculative software with no near-term monetization over the next 1-2 weeks; a strong debut could extend the “AI capital markets reopen” trade, but be ready to exit if day-2 retention fails.
• Use QQQ strength to sell upside calls or run a short-dated call spread if geopolitical headlines fade: the index is near records, but the risk/reward is worse than single-name quality longs because the market is ignoring headline shock risk from trade/Taiwan.
• Contrarian setup: buy a small starter long in under-owned networking/optics suppliers on any post-CSCO pullback over the next 3-10 sessions, since Cisco’s capex signal can cascade into the broader data-center supply chain even if the headline winner remains CSCO.